APEIRON INVESTMENT GROUP LTD. sold 3.44M shares of SENSEI BIOTHERAPEUTICS, INC. on the open market
Open‑market sale worth $5.44M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/2/2023ACC: 0000921895-23-001420
10% Owner
Since Jul 2022
-3.44M
Net shares
Net seller
$5.44M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.44M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−2.49M
Price / share
$1.58
Trade value
$3.93M
% of position
New position
6/1/2023
2.49M→0.00
Common Stock
Indirect
Shares
−955.74K
Price / share
$1.58
Trade value
$1.51M
% of position
New position
6/1/2023
955.74K→0.00
Total
Net shares
−3.44M
Net value
-$5.44M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/1/2023 | S · Sale | −2.49M | $1.58 | $3.93M | New position | 2.49M | 0.00 |
| Common Stock Indirect | 6/1/2023 | S · Sale | −955.74K | $1.58 | $1.51M | New position | 955.74K | 0.00 |
| Total | −3.44M | -$5.44M | ||||||
Derivative Transactions0
No derivative transactions reported